EP3292141
Samrunaprótín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.4.2016EP published:
12.2.2020EP application number:
16721605.0
EP translation filed:
12.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
27.4.2036Expiry date:
27.4.2026Next due date:
30.4.2026
Title:
FUSION PROTEINS
Timeline
Today
28.4.2016EP application
12.2.2020EP Publication
12.3.2020Translation submitted
15.4.2020Registration published
27.4.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BALDWIN, David BruceAddress:
Indianapolis, Indiana 46206-6288, US
Name:
BEALS, John MichaelAddress:
Indianapolis, Indiana 46206-6288, US
Name:
DAY, Jonathan WesleyAddress:
Indianapolis, Indiana 46206-6288, US
Name:
DICKINSON, Craig DuaneAddress:
Indianapolis, Indiana 46206-6288, US
Name:
KORYTKO, Andrew IhorAddress:
Indianapolis, Indiana 46206-6288, US
Name:
LAZAR, Gregory AlanAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562158079 PDate:
7.5.2015Country:
US
Classification
Categories:
C07K 14/62, A61K 38/28, C12N 15/62
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.3.2020
Expires: 27.4.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 23.3.2021
Expires: 27.4.2022
Payer: Patice ehf.
Number: 7
Paid: 22.3.2022
Expires: 27.4.2023
Payer: Patice ehf.
Number: 8
Paid: 25.3.2023
Expires: 27.4.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 20.3.2024
Expires: 27.4.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.4.2025
Expires: 27.4.2026
Payer: Árnason Faktor ehf.